When BM-MSCs were applied with a BMP-2 gene knockdown on H295R cells, it showed higher expression of genes for the production of androgen, which shows BMP-2 is part of the secretome responsible for therapeutic characteristics of BM-MSCs in PCOS [57]. This evidence concerns the gene BMP2 and polycystic ovary syndrome.